WALTHAM, Mass.--(BUSINESS WIRE)--
PerkinElmer,
Inc. (NYSE: PKI), a global leader focused on improving the health
and safety of people and the environment, announced today that it has
priced an offering of $500,000,000 aggregate principal amount of 5.00%
senior notes due 2021 at an issue price of 99.372% of the principal
amount.
The issuance of the notes is expected to close on October 25, 2011. The
notes will pay interest on a semi-annual basis.
The company plans to use the proceeds of the offering to fund, in part,
the company's acquisition of Caliper Life Sciences, Inc. (NASDAQ: CALP).
The aggregate purchase price of the Caliper acquisition is estimated to
be approximately $600 million net of acquired cash. The Caliper
acquisition has been separately announced by the company.
The joint book-running managers for the offering are Merrill Lynch,
Pierce, Fenner & Smith Incorporated, Barclays Capital Inc. and Deutsche
Bank Securities Inc.
PerkinElmer has filed a registration statement on Form S-3 (including a
prospectus) with the Securities and Exchange Commission (the "SEC").
Prospective investors should read the prospectus forming a part of that
registration statement and the preliminary prospectus supplement related
to the offering and the other documents that the company has filed with
the SEC for more complete information about the company and this
offering. These documents are available at no charge by visiting EDGAR
on the SEC Website at www.sec.gov.
Alternatively, these documents will be made available upon request by
the company or by any underwriter or dealer participating in the
offering. Interested parties may obtain a prospectus or the related
preliminary prospectus supplement from Merrill Lynch, Pierce, Fenner &
Smith Incorporated by directing a request to dg.prospectus_requests@baml.com,
or by calling 1-800-294-1322; or from Barclays Capital Inc. by directing
a request to Barclays Capital Inc., c/o Broadridge Financial Solutions,
1155 Long Island Avenue, New York, NY 11717, or by calling
1-888-603-5847; or from Deutsche Bank Securities Inc. by directing a
request to 100 Plaza One, Floor 2, Jersey City, NJ, 07311-3901, Attn:
Prospectus Department, or via email at prospectus.cpdg@db.com,
or by calling 1-800-503-4611.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy the notes, nor shall there be any offer,
solicitation or sale of the notes in any jurisdiction in which such
offer, solicitation or sale would be unlawful prior to the registration
or qualification under the securities laws of any such jurisdiction.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and
safety of people and the environment. The Company reported revenue of
approximately $1.7 billion in 2010, has about 6,200 employees serving
customers in more than 150 countries, and is a component of the S&P 500
Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
PerkinElmer, Inc.
Investor Relations:
David C. Francisco,
781-663-5677
Vice President, Investor Relations
dave.francisco@perkinelmer.com
or
Media
Contacts:
Stephanie R. Wasco, 781-663-5701
Vice President,
Corporate Communications
stephanie.wasco@perkinelmer.com
or
Mario
Fante, 781-663-5602
Corporate Public Relations Manager
mario.fante@perkinelmer.com
Source: PerkinElmer, Inc.
News Provided by Acquire Media